Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_assertion type Assertion NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_head.
- NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_assertion description "[Multivariate linear regression analysis revealed that AhR expression appeared to be involved in the regulation of CYP1A2, 2E1, 2D6, UGT1A, MDR1/3, MRP2/3, NTCP and OCT1 in the livers of patients with chronic hepatitis C. These results suggest that downregulation of AhR during the progression of liver fibrosis is associated with decreased expression levels of these phase I and II enzymes and drug transporters during inflammation-related signal transduction between AhR and other nuclear receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_provenance.
- NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_assertion evidence source_evidence_literature NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_provenance.
- NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_assertion SIO_000772 22166890 NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_provenance.
- NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_assertion wasDerivedFrom befree-2016 NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_provenance.
- NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_assertion wasGeneratedBy ECO_0000203 NP946379.RAlp2jFz8q4QGqOwFTV-l3kDCVEby4Ncq237t_zp3DJ2w130_provenance.